Skip to main content
. Author manuscript; available in PMC: 2017 Mar 25.
Published in final edited form as: J Clin Psychopharmacol. 2013 Apr;33(2):226–230. doi: 10.1097/JCP.0b013e31828701d0

Table 2.

Side effect assessment*

Insulin (N=21) Placebo (N=24) p value

Adverse event N % N %
Wheezing 2 10 0 0 0.41
Coughing 2 10 0 0 0.41
Trouble breathing 1 5 0 0 1.00
Nasal congestion 2 10 1 4 0.92
Hypersalivation 1 5 0 0 1.00
Nausea 1 5 0 0 1.00
Vomiting 1 5 0 0 1.00
Numbness 1 5 0 0 1.00
Poor concentration 2 10 1 4 0.92
Confusion 1 5 0 0 1.00
Insomnia 4 19 0 0 0.09
Drowsiness 2 10 0 0 0.92
*

occurred in more than 5% of the subjects taking insulin and was at least twice as common as in the placebo group.